# Early Immunosuppressants in Crohn's Disease

> **NCT00546546** · PHASE4 · COMPLETED · sponsor: **Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives** · enrollment: 120 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** early immunosuppressants (azathioprine, methotrexate)

## Key facts

- **NCT ID:** NCT00546546
- **Lead sponsor:** Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2012-12
- **Final completion:** 2013-06
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2015-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00546546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00546546, "Early Immunosuppressants in Crohn's Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00546546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*